Litcius/Paper detail

Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest

Paul Moss, Francis Bérenbaum, Giuseppe Curigliano, Ayelet Grupper, Thomas Berg, Shanti Pather

2022Vaccine16 citationsDOIOpen Access PDF

Topics & Concepts

VaccinationMedicineDiseasePopulationImmunologyTransmission (telecommunications)Intensive care medicineEnvironmental healthInternal medicineEngineeringElectrical engineeringSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesVaccine Coverage and Hesitancy
Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest | Litcius